Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia
Ricardo Parrondo(Jacksonville College), Sikander Ailawadhi(Jacksonville College), Taimur Sher(Mayo Clinic in Florida), Craig B. Reeder(Mayo Clinic in Arizona), Victoria R. Alegria(Jacksonville College), Muhamad Alhaj Moustafa(Jacksonville College), Prashant Kapoor, Rahma Warsame, Wilson I. Gonsalves(Mayo Clinic in Arizona), Eli Muchtar(Mayo Clinic), Vivek Roy(Jacksonville College), David Dingli, Suzanne R. Hayman, Asher Chanan‐Khan(WinnMed)
Cited by 17
Related Papers
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
|Antimicrobial Agents and Chemotherapy|2010|727
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
|Leukemia|2011|721
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma
|New England Journal of Medicine|2023|695